Rostislav Christov Raykov Sells 2,431 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock

Fennec Pharmaceuticals Inc. (TSE:FRX) Director Rostislav Christov Raykov sold 2,431 shares of Fennec Pharmaceuticals stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of C$6.67, for a total value of C$16,212.34.

Rostislav Christov Raykov also recently made the following trade(s):

• On Wednesday, September 4th, Rostislav Christov Raykov sold 2,431 shares of Fennec Pharmaceuticals stock. The shares were sold at an average price of C$7.45, for a total value of C$18,115.81.

Fennec Pharmaceuticals Stock Performance

Shares of Fennec Pharmaceuticals stock opened at C$6.26 on Friday. The company has a market capitalization of C$171.27 million, a PE ratio of 69.56 and a beta of 0.26. The company has a 50-day simple moving average of C$7.46 and a two-hundred day simple moving average of C$9.77. Fennec Pharmaceuticals Inc. has a one year low of C$6.14 and a one year high of C$15.43. The company has a debt-to-equity ratio of 1,040.68, a quick ratio of 10.17 and a current ratio of 8.02.

Fennec Pharmaceuticals (TSE:FRX) last issued its quarterly earnings data on Tuesday, August 13th. The biopharmaceutical company reported C($0.27) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C$0.08 by C($0.35). Fennec Pharmaceuticals had a negative return on equity of 1,005.59% and a net margin of 5.59%. The firm had revenue of C$9.94 million during the quarter, compared to analysts’ expectations of C$18.67 million. Research analysts expect that Fennec Pharmaceuticals Inc. will post 0.6025751 EPS for the current fiscal year.

About Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.